Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

Population pharmacokinetics of tacrolimus in paediatric bone marrow transplantation and implementation in a dose adaptation tool

J.E. Wallin, L. E. Friberg, A. Fasth, C. E. Staatz

Ann Transplant 2008; 13(1): 39-39 :: ID: 880201

Abstract

Background: To characterise the population pharmacokinetics of tacrolimus in paediatric BMT recipients and to develop a dosing tool to assist with initial dosage selection.
Material/Methods: Data were collected retrospectively from the medical records of 22 children. Tacrolimus treatment started 36 hours pre-transplant as a continuous intravenous infusion of 0.03 mg/kg/day. Patients were converted to oral therapy two to three weeks post-transplant. Population pharmacokinetic analysis was performed using NONMEM. A macro was constructed in MS Excel, utilising Bayesian forecasting techniques and the population model, to recommend an initial dose in new individuals in order to achieve a target concentration of 12 ng/ml at the time of transplantation.
Results: 743 blood concentration-time points were analysed. Data were collected for a median of 95 days post transplant. All 514 samples collected during oral therapy represented trough values, and samples during infusion were collected 3 times/week. A one-compartment model with first order absorption and elimination was selected. In the final model, typical parameter values were clearance (CL) = 0.135L/h/kg0.75, distribution volume (V) =7.09L/kg and bioavailability (F) = 14.4%. Inter-individual variability in CL, V and F was 56%, 97% and 58%, respectively. Covariate analysis suggested CL positively correlated with creatinine clearance and F decreased with time post-transplant. Use of the model in the Macro, based on a 'typical patient' indicated a 50% higher dose than that currently used initially (0.03 mg/kg/day) is needed to achieve the target trough concentration.
Conclusions: The developed dosage adaptation tool may assist with tacrolimus dosing in paediatric BMT recipients, utilizing TDM concentrations.

Keywords: Creatinine, Tacrolimus, NONMEM

0 Comments

In Press

20 Jan 2022 : Original article  

Impact on Waitlist Outcomes from Changes in the Medical Eligibility of Candidates for Simultaneous Liver-Ki...

Ann Transplant In Press; DOI: 10.12659/AOT.934850  

19 Jan 2022 : Original article  

Carbohydrate Metabolism Disorders in Relation to Cardiac Allograft Vasculopathy (CAV) Intensification in He...

Ann Transplant In Press; DOI: 10.12659/AOT.933420  

18 Jan 2022 : Original article  

PLGA+Fe₃O₄+PFP Nanoparticles Drug-Delivery Demonstrates Potential Anti-Tumor Effects on Tumor Cells

Ann Transplant In Press; DOI: 10.12659/AOT.933246  

17 Jan 2022 : Original article  

Impact of Thyroid Incidentaloma on Liver Transplant: A Study of 1010 Recipients at a Single Center

Ann Transplant In Press; DOI: 10.12659/AOT.934988  

Most Viewed Current Articles

29 Dec 2021 : Original article  

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

22 Dec 2021 : Original article  

Comparison of Coronary Artery Calcium Scoring with Dobutamine Stress Echo for Detection of Coronary Artery ...

DOI :10.12659/AOT.934163

Ann Transplant 2021; 26:e934163

12 Jan 2022 : Original article  

Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...

DOI :10.12659/AOT.934738

Ann Transplant 2022; 27:e934738

01 Dec 2021 : Original article  

Solid-Phase C1q/C3d Fixing Readouts Correlate with High Median Fluorescence Intensity (MFI) De Novo Donor-S...

DOI :10.12659/AOT.934175

Ann Transplant 2021; 26:e934175

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358